期刊文献+

慢性胰腺炎的个体化外科干预 被引量:2

Individualized surgical treatment for chronic pancreatitis
原文传递
导出
摘要 慢性胰腺炎发病机制复杂,病情进展多变,导致外科干预时机及手术方式的选择存在一定困难。慢性胰腺炎的治疗应依据个体化原则去除病灶,尽量保存正常胰腺实质,延缓胰腺内、外分泌功能损害的进程,改善患者生命质量,降低胰腺癌发生的风险。慢性胰腺炎患者早期可考虑保守和内镜治疗,胰管梗阻、狭窄合并结石、胰腺实质广泛钙化等慢性胰腺炎患者则需手术治疗。Frey术适合以胰管扩张和胰管结石为主的慢性胰腺炎患者,Beger术适合以胰头部炎性肿块或胰头部钙化为主的慢性胰腺炎患者。 Because of the complex pathogenesis and progressive development, it is difficult to define the optimal surgical time and procedure for chronic pancreatitis. The indi- vidualized treatment of chronic pancreatitis should resect the inflammatory mass of the head of the pancreas and preserve the pancreatic parenchyma to postpone the injury of pancreatic func- tion and improve life quality as well as decrease the risk for carcinogenesis of pancreatic cancer. Conservative and endoscopic treatment can be considered in the early stage, while surgical intervention should be applied for chronic pancreatitis with stenosis or obstruction of pancreatic duct and calcification of the pancreatic parenchyma. Frey procedure can be performed on patients only with stone in or dilation of pancreatic duct; patients with obvious inflammatory mass or calcification of the head of the pancreas should receive Beger procedure to decrease the morbidity of pancreatic cancer.
作者 王春友 赵刚
出处 《中华消化外科杂志》 CAS CSCD 北大核心 2014年第4期241-243,共3页 Chinese Journal of Digestive Surgery
关键词 慢性胰腺炎 个体化治疗 外科干预 Chronic pancreatitis Individualizedtreatment Surgical treatment
  • 相关文献

参考文献12

  • 1Raimondi S, Lowenfels AB, Morselli-Labate AM, et al. Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection[J]. Best Pract Res Clin Gastroenterol, 20 I 0 , 24 ( 3 ) : 349-358.
  • 2Kudo Y, Kamisawa T, Anjiki H, et al. Incidence of and risk factors for developing pancreatic cancer in patients with chronic pancreatitis] J]. Hepatogastroenterology ,2011 ,58 (106) :609-611.
  • 3Forsmark CEo Management of chronic pancreatitis[J]. Gastroenterology ,2013 ,144 (6) : 1282-1291.
  • 4Nealon WH, Matin S. Analysis of surgical success in preventing recurrent acute exacerbations in chronic pancreatitis[J]. Ann Surg,2001 ,233(6) :793-800.
  • 5Ihse I, Borch K, LarssonJ. Chronic pancreatitis: results of operations for relief of pain[J]. WorldJ Surg,1990,14( I) :53-58.
  • 6Raimondi S, Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: an overview[J]. Nat Rev Gastroenterol Hepatol , 2009,6(12) :699-708.
  • 7Wani N A, Parray FQ, Wani MA. Is any surgical procedure ideal for chronic pancreatitis?[J]. IntJ Surg,2007,5 (I) :45-56.
  • 8王春友,赵刚.十二指肠胰头切除术的适应证选择与手术策略[J].中华普外科手术学杂志(电子版),2013,7(3):15-17. 被引量:6
  • 9Zhao G, Qin Q, ZhangJ, et al. Hypermethylation of HICI promoter and aberrant expression of HIClISIRTl might contribute to the carcinogenesis of pancreatic cancer[J]. Ann Surg Oncol , 2013 ,20 Suppl3 :S301-311.
  • 10MarkowitzJS, Rattner DW, Warshaw AL. Failure of symptomatic relief after pancreaticojejunal decompression for chronic pancreatitis. Strategies for salvage[J]. Arch Surg,1994,129:374-380.

二级参考文献15

  • 1Varghese TK, Bell RH Jr. Duodenum-preserving head resection for chronic pancreatitis: an institutional experience and national smwey of usage. Surgery,2007,142(4) :588-593 ; discussion 593. el-3.
  • 2Wang C, Liu T, Wu H, et al. Duodenum-preserving total pancreatic head resection without segment resection of the duodenum for chron- ic pancreatitis. Langenbecks Arch Surg,2009,394 (3) :563-568.
  • 3Strobel O, Btichler MW, Werner J. Surgical therapy of chronic pancreatitis: indications, techniques and resuhs. Int J Surg,2009, 7(4) :305-312.
  • 4Hardacre JM, McGee MF, Stellato TA, et al. An aggressive surgical approach is warranted in the management of cystic pancreatic neo- plasms. Am J Surg,2007,193 (3) :374-378 ; discussion 378-379.
  • 5Farnell MB. Surgical management of intraductal papillary nmcinous neoplasm (IPMN) of the pancreas. J Gastrointest Surg,2008,12 (3) :414-416.
  • 6Lafemina J, Katabi N, Klimstra D, et al. Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation. Ann Surg Oncol,2013,20(2) :440-447.
  • 7Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neo- plasms and mucinous cystic neoplasms of the pancreas. Pancre- atology ,2006,6 : 17-32.
  • 8Bassi C, Sarr MG, Lillemoe KD, et al. Natural history of intraductal papillary mucinous neoplasms (IPMN) : current evidence and impli- cations for management. J Ga,:tmintest Surg,2008,12 (4) :645-650.
  • 9Martin RC, Kooby DA, Weber SM,et al. Analysis of 6,747 pan- creatic neuroendocrine tumors for a proposed staging system. J Gas- trointest Surg,2011,15( 1 ) :175-183.
  • 10Batcher E, Madaj P, Gianoukakis AG. Pancreatic neuroendocrine tumors. Endocr Res, 2011,36 ( 1 ) : 35 -43.

共引文献5

同被引文献11

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部